Recent News

• 06.04.2025 - TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
• 06.04.2025 - TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
• 05.30.2025 - David Patience
• 05.30.2025 - TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
• 05.30.2025 - TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
• 05.15.2025 - TriSalus Life Sciences First Quarter 2025 Earnings Call
• 05.15.2025 - TriSalus Life Sciences First Quarter 2025 Earnings Call
• 05.15.2025 - TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
• 05.15.2025 - TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

Recent Filings

• 05.30.2025 - EFFECT Notice of Effectiveness
• 05.30.2025 - 8-K Current report
• 05.30.2025 - EX-99.1 EX-99.1
• 05.30.2025 - S-3 Registration statement under Securities Act of 1933
• 05.30.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.21.2025 - 4 Statement of changes in beneficial ownership of securities